Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine
- 1 October 2016
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 93, 147-162
- https://doi.org/10.1016/j.ejps.2016.08.021
Abstract
No abstract availableKeywords
Funding Information
- Science & Engineering Research Board (SR/FT/LS-107/2012)
- DST
This publication has 100 references indexed in Scilit:
- BSA-PLGA-Based Core-Shell Nanoparticles as Carrier System for Water-Soluble DrugsPharmaceutical Research, 2013
- Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapyBiomaterials, 2013
- Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticlesInternational Journal of Pharmaceutics, 2012
- EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityJournal of Controlled Release, 2012
- Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancerNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluationBiomedical Microdevices, 2011
- In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticlesInternational Journal of Pharmaceutics, 2011
- Nanonization strategies for poorly water-soluble drugsDrug Discovery Today, 2011
- Synthesis of biodegradable multiblock copolymers by click coupling of RAFT-generated heterotelechelic polyHPMA conjugatesReactive and Functional Polymers, 2011
- Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenograftsEuropean Journal of Cancer, 1995